Using Pharmacokinetic/efficacy Modeling to Identify the Optimal Schedule for MLN0264, an Anti- Guanylyl Cyclase C (GCC) Antibody-Drug Conjugate, in a Range of Xenograft Models
CANCER RESEARCH（2014）
Key words
Antibody Pharmacokinetics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined